Paul E Goss

Paul E Goss

UNVERIFIED PROFILE

Are you Paul E Goss?   Register this Author

Register author
Paul E Goss

Paul E Goss

Publications by authors named "Paul E Goss"

Are you Paul E Goss?   Register this Author

100Publications

2723Reads

5Profile Views

Endometrial Cancer in Brazil: Preparing for the Rising Incidence.

Rev Bras Ginecol Obstet 2018 Oct 23;40(10):577-579. Epub 2018 Oct 23.

Global Cancer Institute, Boston, Masachussets, United States.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1673644
Publisher Site
http://dx.doi.org/10.1055/s-0038-1673644DOI Listing
October 2018

Disparities in Breast, Lung, and Cervical Cancer Trials Worldwide.

J Glob Oncol 2018 09;4:1-11

Ramya Ramaswami, Imperial College London, Hammersmith Hospital, London, United Kingdom; Eduardo Paulino, Adriana Barrichello, Angelica Nogueira-Rodrigues, Alexandra Bukowski, Jessica St. Louis, and Paul E. Goss, The Global Cancer Institute; and Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JGO.17.00226
Publisher Site
http://dx.doi.org/10.1200/JGO.17.00226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223472PMC
September 2018

A Rare Presentation of Primary Breast Carcinoma in the Vulva: A Case Report and Literature Review.

Clin Breast Cancer 2018 06 23;18(3):e291-e294. Epub 2017 Jun 23.

The Global Cancer Institute, Boston, MA; MGH-Avon Global Breast Cancer Program, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.06.004DOI Listing
June 2018

, a Novel Transcription Factor and a Coregulator of Nuclear Factor B p65: Single Nucleotide Polymorphism and Estrogen Dependence.

J Pharmacol Exp Ther 2018 Jun 28;365(3):700-710. Epub 2018 Mar 28.

Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics (M.H., E.L.d.R., C.Z., L.W., H.L., R.M.W.), and Division of Medical Oncology, Department of Oncology (J.N.I.), Mayo Clinic, Rochester, Minnesota; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts (P.E.G.); Canadian Cancer Trials Group, Kingston, Ontario, Canada (L.E.S.); and RIKEN Center for Integrative Medical Science, Yokohama, Japan (M.K.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.118.247718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954488PMC
June 2018

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.

J Clin Oncol 2018 02 12;36(6):563-571. Epub 2018 Jan 12.

Julie Lemieux, Centre Hospitalier Universitaire de Québec, Quebec City, Quebec; Michael D. Brundage, Cancer Centre of Southeastern Ontario at Kingston General Hospital; Wendy R. Parulekar, Kate Whelan, and Dongsheng Tu, Canadian Cancer Trials Group, Kingston; Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto; Timothy J. Whelan, McMaster University and Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada; Paul E. Goss, Massachusetts General Hospital Cancer Center, Boston, MA; James N. Ingle, North Central Cancer Treatment Group, Mayo Clinic, Rochester, NY; Paul Celano; Greater Baltimore Medical Center, Baltimore, MD; Hyman Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Julie Gralow, University of Washington, Seattle, WA; and Kathrin Strasser-Weippl, Wilhelminen Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.75.7500
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.75.7500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815404PMC
February 2018

Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review.

Breast 2017 Oct 18;35:136-141. Epub 2017 Jul 18.

Global Cancer Institute, 25 New Chardon St., P.O. Box 8736, Boston, MA, 02114, USA; MGH-Avon Global Cancer Research Program, Massachusetts General Hospital, 10 North Grove St., Boston, MA, 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09609776173052
Publisher Site
http://dx.doi.org/10.1016/j.breast.2017.07.008DOI Listing
October 2017

Barriers to Primary Debulking Surgery for Advanced Ovarian Cancer in Latin America.

Int J Gynecol Cancer 2017 10;27(8):1645-1649

*Brazilian National Cancer Institute; †Grupo COI, Rio de Janiero, Brazil; ‡Global Cancer Institute, Boston, MA; §Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; ∥Wilheminen Hospital, Vienna Austria; ¶MGH-Avon Global Cancer Program; and #Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000001098DOI Listing
October 2017

Patient Navigation to Improve Access to Breast Cancer Care in Brazil.

J Glob Oncol 2017 Oct 30;3(5):433-437. Epub 2016 Nov 30.

, , and , Avon International Breast Cancer Research Program, Massachusetts General Hospital; , , , , , , , and , The Global Cancer Institute, Boston, MA; and , Instituto Nacional de Câncer José Alencar Gomes da Silva; Rio de Janeiro; , Federal University of Minas Gerais, Belo Horizonte, Brazil; and and , Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2016.006726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646893PMC
October 2017

Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-B Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response.

Mol Pharmacol 2017 08 14;92(2):175-184. Epub 2017 Jun 14.

Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics (M.-F.H., L.W., R.M.W.), Division of Medical Oncology, Department of Oncology (J.N.I.), and Division of Biomedical Statistics and Informatics, Department of Health Sciences Research (K.R.K.), Mayo Clinic, Rochester, Minnesota; Department of Emergency Medicine, Vanderbilt Medical Center, Nashville, Tennessee (T.B.); Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts (P.E.G.); NCIC Clinical Trials Group, Kingston, Ontario Canada (L.E.S.); and RIKEN Center for Integrative Medical Science, Tsurumi-ku, Yokohama, Japan (T.M., M.K.)

View Article

Download full-text PDF

Source
http://molpharm.aspetjournals.org/lookup/doi/10.1124/mol.117
Publisher Site
http://dx.doi.org/10.1124/mol.117.108340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508195PMC
August 2017

End-of-Life Care in Latin America.

J Glob Oncol 2017 Jun 24;3(3):261-270. Epub 2016 Aug 24.

and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; , , , and ; The Global Cancer Institute; , , and , Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA; , , and , Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany; and , Universidad Peruana Cayetano Heredia, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2016.005579DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493222PMC
June 2017

The Potential Role of Patient Navigation in Low- and Middle-Income Countries for Patients With Cancer.

JAMA Oncol 2016 Aug;2(8):994-5

Global Cancer Institute, Boston, Massachusetts3Avon International Breast Cancer Program, Massachusetts General Hospital Cancer Center, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0766DOI Listing
August 2016

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

N Engl J Med 2016 Jul 5;375(3):209-19. Epub 2016 Jun 5.

From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1604700DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024713PMC
July 2016

Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.

Pharmacogenomics 2015 12;16(11):1227-9. Epub 2015 Aug 12.

GlaxoSmithKline Research & Development, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.69DOI Listing
June 2016

Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.

Mol Endocrinol 2016 Mar 11;30(3):382-98. Epub 2016 Feb 11.

Division of Clinical Pharmacology (M.-F.H., M.L., L.W., R.M.W.), Department of Molecular Pharmacology and Experimental Therapeutics, Division of Rheumatology (M.-F.H., T.B.), Department of Medicine, Division of Biomedical Statistics and Informatics (K.R.K.), Department of Health Sciences Research, and Division of Medical Oncology (M.P.G., J.N.I.), Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905; Division of Hematology/Oncology (P.E.G.), Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard University, Boston, Massachusetts 02114; National Cancer Institute of Canada Clinical Trials Group (L.E.S.), Kingston, Ontario, Canada K7L 3N6; and RIKEN Center for Integrative Medical Science (M.K.), Yokohama 230-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/me.2015-1267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771694PMC
March 2016

Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.

Cancer 2016 Jan 12;122(2):184-8. Epub 2015 Oct 12.

Avon International Breast Cancer Research Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29714DOI Listing
January 2016

Current Status and Future Projections of Breast Cancer in Asia.

Breast Care (Basel) 2015 Dec 15;10(6):372-8. Epub 2015 Dec 15.

Center for Oncology, Hematology and Palliative Care, Wilhelminen Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000441818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789872PMC
December 2015

Competing risks in low-risk breast cancer.

Am Soc Clin Oncol Educ Book 2013 :32-9

From the Harvard Medical School and Avon Breast Cancer Center of Excellence, Massachusetts General Hospital Cancer Center, Boston, MA; Center for Oncology, Hematology and Palliative Care, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EdBook_AM.2013.33.32DOI Listing
November 2015

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2015 Jun 6;33(17):1902-9. Epub 2015 Apr 6.

Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451173PMC
June 2015

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

J Clin Oncol 2015 Jan 15;33(3):265-71. Epub 2014 Dec 15.

Vered Stearns, Kimmel Cancer Center, Johns Hopkins, Baltimore, MD; Judith-Anne W. Chapman, Aurélie Le Maitre, Jessica Kundapur, and Lois E. Shepherd, NCIC Clinical Trials Group, Queen's University, Kingston; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Cynthia X. Ma, Siteman Cancer Center, Washington University, St Louis, MO; Matthew J. Ellis, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; James N. Ingle, Mayo Clinic, Rochester, MN; G. Thomas Budd, Cleveland Clinic, Cleveland, OH; George W. Sledge, Stanford University, San Francisco, CA; Pedro E.R. Liedke and Paul E. Goss, Harvard University; Paul E. Goss, Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA; Manuela Rabaglio, Inselspital University Hospital and International Breast Cancer Study Group Coordinating Center, Berne, Switzerland; and Pedro E.R. Liedke, Hospital de Clínicas de Porto Alegre and Instituto do Cancer Mãe de Deus, Oncologia, Porto Alegre, Rio Grande do Sul, Brazil.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/3/265.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.6926
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.6926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289722PMC
January 2015

Extending endocrine therapy in women with hormone receptor-positive breast cancer.

Authors:
Paul E Goss

Clin Adv Hematol Oncol 2015 Jan;13(1):20-2

Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
January 2015

Reply to P. Niravath et Al.

J Clin Oncol 2014 Nov 25;32(33):3780-1. Epub 2014 Aug 25.

Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.9235DOI Listing
November 2014

Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.

Mol Endocrinol 2014 Oct 22;28(10):1740-51. Epub 2014 Aug 22.

Division of Clinical Pharmacology (M.L., L.W., R.M.W.), Department of Molecular Pharmacology and Experimental Therapeutics; Departments of Oncology (J.N.I.) and Health Sciences Research (A.B., G.D.J., E.E.C., D.J.S.); and Division of Endocrinology (S.K.), Mayo Clinic, Rochester, Minnesota 55905; Massachusetts General Hospital (P.E.G.), Harvard University, Boston, Massachusetts 02114; Rikagaku Kenkyūsho Center for Integrative Medical Science (M.K., Y.F.), Yokohama, Japan 230-0045; School of Medicine (Y.N.), Chicago University, Chicago, Illinois 60637; National Cancer Institute of Canada Clinical Trials Group (J.-A.W.C., L.E.S.), Kingston, Ontario, Canada K7L 3N6; and Division of Oncology (M.J.E.), Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/me.2014-1147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179631PMC
October 2014

Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury.

J Clin Oncol 2014 Aug 31;32(22):2296-303. Epub 2014 Mar 31.

Daniel J. Schaid and Shannon K. McDonnell, Mayo Clinic, Rochester, MN; Colin F. Spraggs and Charles J. Cox, GlaxoSmithKline Research and Development, Stevenage, Hertfordshire; Joan Curran, GlaxoSmithKline Research and Development, London, United Kingdom; Laura R. Parham, GlaxoSmithKline Research and Development, Research Triangle Park, NC; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Dianne M. Finkelstein and Paul E. Goss, Massachusetts General Hospital, Boston, MA; and Erica Rappold and Lon R. Cardon, GlaxoSmithKline Research and Development, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.9867DOI Listing
August 2014

Breast cancer in China.

Lancet Oncol 2014 Jun;15(7):e279-89

International Breast Cancer Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045137056
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(13)70567-9DOI Listing
June 2014

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.

J Clin Oncol 2014 May 7;32(14):1427-36. Epub 2014 Apr 7.

Elizabeth Maunsell, Centre de recherche du Centre hospitalier universitaire (CHU) de Québec, (Axe Oncologie), Québec; Pierre Dubé, Hôpital Maisonneuve-Rosemont, Montreal, QC; Andrew L. Cooke, CancerCare Manitoba, Winnipeg, MB; Silvana Spadafora, Algoma District Cancer Program, Sault Ste. Marie, ON; Lavina Lickley, Women's College Hospital; Angela M. Cheung, University Health Network, University of Toronto, Toronto; Dianne Johnston, Andrea Hiltz, Michael Brundage, Dongsheng Tu, and Harriet Richardson, National Cancer Institute of Canada Clinical Trials Group; Joseph Pater, Queens University, Kingston, ON; Susan L. Ellard, British Columbia Cancer Agency-Southern Interior, Kelowna; Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, BC, Canada; Paul E. Goss, Massachusetts General Hospital, Boston, MA; Rowan T. Chlebowski, University of California at Los Angeles Medical Centre, Torrance, CA; James N. Ingle and Sandhya Pruthi, Mayo Clinic, Rochester, MN; José E. Alés Martínez, Hospital N. S. Sonsoles, Ávila; Amparao Ruiz, Instituto Valenciano de Oncologia, Valencia, Spain; Gloria E. Sarto, Center for Women's Health & Health Research, University of Wisconsin, Madison, WI; Carol J. Fabian, University of Kansas Medical Center, Kansas City, KS; Pascal Pujol, CHU-Hôpital Arnaud de Villeneuve, Montpellier, France; Susan Hendrix, Hutzel Women's Health Specialists, Detroit, MI; Debra W. Thayer, MedStar Health Research Institute, Hyattsville, MD; Kendrith M. Rowland, Carle Cancer Centre/Mills Breast Cancer Institute, Urbana, IL; and Jean Wactawski-Wende, State University of New York at Buffalo, Buffalo, NY.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/04/03/JCO.2013.51
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.51.2483
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.2483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879707PMC
May 2014

Intermittent letrozole therapy for metastatic breast cancer: case reports and literature review.

Clin Breast Cancer 2014 Apr 25;14(2):e41-5. Epub 2013 Oct 25.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2013.10.009DOI Listing
April 2014

Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.

Cancer Epidemiol Biomarkers Prev 2014 Jan 28;23(1):126-33. Epub 2013 Oct 28.

Authors' Affiliations: Brazilian Breast Cancer Study Group (GBECAM); Federal University of Sao Paulo (UNIFESP), Sao Paulo, SP, Brazil; Hospital de Clínicas de Porto Alegre; PUCRS School of Medicine Porto Alegre, Porto Alegre, RS, Brazil; National Cancer Institute of Brazil (INCA), Rio de Janeiro, RJ, Brazil; Massachusetts General Hospital, Avon International Breast Cancer Program; and Massachusetts General Hospital Biostatistics Unit, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0693DOI Listing
January 2014

Suitable trial designs and cohorts for preventive breast cancer agents.

Nat Rev Clin Oncol 2013 Dec 8;10(12):677-87. Epub 2013 Oct 8.

Center for Oncology, Hematology and Palliative Care, Wilhelminen Hospital, Montleartstrasse 36, A-1160 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2013.174DOI Listing
December 2013

Reply to e. Esin et al.

J Clin Oncol 2013 Sep 5;31(27):3439-40. Epub 2013 Aug 5.

Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4893DOI Listing
September 2013

Cancer control in Chile - Authors' reply.

Lancet Oncol 2013 Aug;14(9):e338

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70354-1DOI Listing
August 2013

Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.

Breast 2013 Aug;22 Suppl 2:S171-5

Center for Oncology, Hematology and Palliative Care, Wilhelminen Hospital, Montleartstr. 36, A-1160 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.07.033DOI Listing
August 2013

Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trial.

Crit Rev Oncol Hematol 2013 Apr 30;86(1):23-32. Epub 2012 Oct 30.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2012.09.013DOI Listing
April 2013

Planning cancer control in Latin America and the Caribbean.

Lancet Oncol 2013 Apr;14(5):391-436

Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451370048
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(13)70048-2DOI Listing
April 2013

Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.

Breast Cancer Res Treat 2012 Dec 23;136(3):769-76. Epub 2012 Oct 23.

Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2294-z
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2294-zDOI Listing
December 2012

Breast cancer in Mexico: a growing challenge to health and the health system.

Lancet Oncol 2012 Aug;13(8):e335-43

Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70246-2DOI Listing
August 2012

Anti-tumor effects of a novel retinoic acid metabolism blocking agent VN/14-1 in the N-methyl-N-nitrosourea-induced rat mammary carcinoma model and its effects on the uterus.

Breast Cancer Res Treat 2012 May 14;133(1):137-44. Epub 2011 Aug 14.

Breast Cancer Research, Massachusetts General Hospital Cancer Center, Breast Cancer Disease Program, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1724-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112508PMC
May 2012

Aromatase inhibitors and musculoskeletal adverse events.

Lancet Oncol 2012 Apr 20;13(4):333-4. Epub 2012 Jan 20.

Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(11)70345-XDOI Listing
April 2012

Breast cancer in Brazil: present status and future goals.

Lancet Oncol 2012 Mar;13(3):e95-e102

International Breast Cancer Research Program, Massachusetts General Hospital Cancer Center, and Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045117032
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(11)70323-0DOI Listing
March 2012

Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression.

Breast Cancer Res 2012 Mar 9;14(2):R41. Epub 2012 Mar 9.

Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446375PMC
March 2012

Denosumab and the current status of bone-modifying drugs in breast cancer.

Acta Oncol 2012 Feb 12;51(2):157-67. Epub 2011 Dec 12.

Department of Medicine, Massachusetts General Hospital, Boston, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2011.633555DOI Listing
February 2012

Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies.

Genet Epidemiol 2012 Jan 7;36(1):3-16. Epub 2011 Dec 7.

Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gepi.20632
Publisher Site
http://dx.doi.org/10.1002/gepi.20632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310255PMC
January 2012

Does tumour dormancy offer a therapeutic target?

Nat Rev Cancer 2010 Dec 4;10(12):871-7. Epub 2010 Nov 4.

Harvard Medical School, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Lawrence House, RH-302, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrc2933
Publisher Site
http://dx.doi.org/10.1038/nrc2933DOI Listing
December 2010

Putative growth characteristics of micrometastatic breast cancer.

Breast Cancer Res 2008 27;10(6):114. Epub 2008 Nov 27.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656890PMC
April 2009

Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats.

J Steroid Biochem Mol Biol 2009 Feb 20;113(3-5):233-40. Epub 2009 Jan 20.

Breast Cancer Research, Massachusetts General Hospital Cancer Center, Breast Cancer Disease Program, Dana Farber/Harvard Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2009.01.005DOI Listing
February 2009

Extending the benefits of adjuvant therapy in early HR+ breast cancer.

Authors:
Paul E Goss

Breast Cancer Res Treat 2008 Dec 11;112 Suppl 1:45-52. Epub 2008 Sep 11.

Massachusetts General Hospital Cancer Center, 55 Fruit Street, Lawrence House, LRH-302, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0129-8DOI Listing
December 2008

Extended adjuvant endocrine therapy in breast cancer: current status and future directions.

Clin Breast Cancer 2008 Oct;8(5):411-7

Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2008.n.049DOI Listing
October 2008

Addressing the future: combination with targeted therapies, adjuvant setting and beyond.

Authors:
Paul E Goss

Anticancer Drugs 2008 Mar;19 Suppl 2:S3-5

Massachusetts General Hospital Cancer Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cad.0000251435.77758.82DOI Listing
March 2008

Letrozole in the extended adjuvant setting: MA.17.

Authors:
Paul E Goss

Breast Cancer Res Treat 2007 3;105 Suppl 1:45-53. Epub 2007 Oct 3.

Massachusetts General Hospital Cancer Center, 55 Fruit Street, Cox Bldg., Room 640, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9698-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001224PMC
February 2008

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.

Cancer 2008 Feb;112(3 Suppl):700-709

Breast Oncology Center, Dana Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23193DOI Listing
February 2008

Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer.

J Natl Cancer Inst 2008 Feb 12;100(4):252-60. Epub 2008 Feb 12.

National Cancer Institute of Canada Clinical Trials Group, Queen's University, 10 Stuart St, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djn014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745611PMC
February 2008

Breast cancer adjuvant endocrine therapy.

Cancer J 2007 May-Jun;13(3):148-55

Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e318074d363DOI Listing
January 2008

The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer.

Oncologist 2008 Jan;13(1):16-24

Massachusetts General Hospital, LRH 308, 55 Fruit Street, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2007-0199DOI Listing
January 2008

Update on the use of letrozole in breast cancer.

Expert Opin Pharmacother 2007 Oct;8(14):2329-45

University of Toronto.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.8.14.2329 DOI Listing
October 2007

Lapatinib-associated toxicity and practical management recommendations.

Oncologist 2007 Jul;12(7):756-65

Massachusetts General Hospital Cancer Center, Gillette Center for Women's Cancers, Lawrence House, LRH 304, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.12-7-756DOI Listing
July 2007